Suven Life Sciences Ltd. | Ownership
Companies that own Suven Life Sciences Ltd.
Aditya Birla Sun Life AMC Ltd.
1,063,000
0.84%
0
0.03%
07/31/2018
Dimensional Fund Advisors LP
588,378
0.46%
117,191
0%
04/30/2018
L&T Investment Management Ltd.
579,646
0.46%
579,646
0.04%
07/31/2018
SBI Life Insurance Co. Ltd. (Investment Portfolio)
492,906
0.39%
-2,467
0.07%
12/31/2017
Van Eck Associates Corp.
436,764
0.34%
0
0.01%
09/05/2018
LIC Mutual Fund Asset Management Ltd.
244,245
0.19%
0
0.23%
08/31/2018
SSgA Funds Management, Inc.
187,524
0.15%
0
0%
09/06/2018
BlackRock Advisors (UK) Ltd.
176,132
0.14%
0
0%
09/05/2018
BNY Mellon Asset Management North America Corp.
125,650
0.1%
1,660
0%
09/06/2018
BlackRock Fund Advisors
110,592
0.09%
0
0%
09/05/2018
| Address |
6th Floor, SDE Serene Chambers
Hyderabad TS 500034
India
|
|
Employees
|
- |
| Website |
http://www.suven.com |
| Updated |
09/14/2018 |
| Suven Life Sciences Ltd. engages on discovering, developing, and commercializing novel pharmaceutical products which are used in classic therapies. It operates through the following segments: Manufacturing, Services, and Research & Development. The Manufacturing segment consists of bulk drugs and intermediates under contract services products are developed and produced on an exclusive basis. |
